These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America. Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411 [TBL] [Abstract][Full Text] [Related]
6. Will sialylation change intravenous immunoglobulin therapy in the future? Käsermann F; Campbell IK Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):100-2. PubMed ID: 25546779 [No Abstract] [Full Text] [Related]
8. Immunoglobulin Replacement Therapy for Primary Immunodeficiency. Sriaroon P; Ballow M Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315 [TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy: the strategic approach to the treatment of patients with severe sepsis]. Pidhirnyĭ IaM Klin Khir; 2005 Jul; (7):32-7. PubMed ID: 16255220 [TBL] [Abstract][Full Text] [Related]
19. Passive immunotherapy of sepsis with intravenous immune globulin: not all IVIg preparations are created equal. Vassilev T; Bauer M Crit Care; 2012 Jan; 16(1):407. PubMed ID: 22277798 [No Abstract] [Full Text] [Related]